Feasibility of Resistance Exercise to Treat Major Depression Via Cerebrovascular Mechanisms
1 other identifier
interventional
9
1 country
1
Brief Summary
This project is a single-arm pilot trial to investigate the feasibility, acceptability, and plausible efficacy of a 16-week resistance exercise training (RET) program for treatment of major depressive disorder.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable major-depressive-disorder
Started Apr 2022
Shorter than P25 for not_applicable major-depressive-disorder
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 4, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 11, 2022
CompletedFirst Submitted
Initial submission to the registry
December 14, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
January 10, 2023
CompletedFirst Posted
Study publicly available on registry
January 25, 2023
CompletedMarch 5, 2024
March 1, 2024
7 months
December 14, 2022
March 4, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (11)
Recruitment and enrollment rates (feasibility)
Screening responses and timestamps will be used to assess the success of recruitment strategies and recruitment rate, calculated by taking the total number of participants recruited (i.e., completed screening survey) divided by the recruitment period duration. Enrollment rate will be calculated by taking the total number of participants enrolled divided by the recruitment period duration.
Week 26
Participant satisfaction (acceptability)
Participant satisfaction will be assessed using a mixed-method approach, capturing self-reported ratings of satisfaction with the RET program (six questions regarding satisfaction with responses ranging from 0-46, with higher scores indicating greater level of satisfaction) corroborated by a qualitative semi-structured interview, with responses analyzed using a thematic qualitative analysis.
Week 26
Retention (acceptability)
The retention rate will be calculated based on the percentage of participants that complete all study visits.
Week 26
Adherence (acceptability)
The adherence rate will be calculated based on the percent of total study visits (i.e., assessment visits and RET sessions) completed within +/-7 days of the scheduled visit date for each participant.
Week 26
Change in exercise preparation habit ratings
To facilitate exercise adherence, participants will develop exercise preparation habit action and coping plans during their baseline visit. These plans will subsequently be assessed weekly during exercise sessions, with participants responding to 3 questions regarding their success in developing exercise preparation habits. Using a 5-point Likert scale ranging from "Never" to "Every Time", participants will report 1) how well they were able to stick to their exercise preparation habit action and coping plans, 2) carried through with preparation steps when their identified cue was encountered, and 3) completed the habit without the planned cue. They were also provided an opportunity to revise their habit action and coping plan if their current plan was not successful the previous week.
Change from week 1 habit ratings at week 16
Change in level of commitment
Participants will be asked to report their current level of commitment to the 16-week program and attending their next exercise session via a visual analogue scale anchored with "0" (0% committed) to "100" (100% committed). They subsequently responded to free-text questions related to what they needed to do or what the research team could do to increase their level of commitment. Next, they answered the question "Will you attend your next RET session?" (yes/no response buttons), and then provided an electronic signature confirming they would attend.
Change from week 1 level of commitment at week 16
Change in depression symptom severity via GRID-Hamilton Depression Rating Scale (HAM-D)
The GRID-HAM-D is a clinician-completed questionnaire that will be used to rate depressive symptom severity. The questionnaire is designed for adults and is used to rate the intensity and frequency of depressive symptoms by probing mood, feelings of guilt, suicidal ideation, insomnia, agitation or retardation, anxiety, weight loss, and somatic symptoms. Clinical Interviewers will follow the Structured Interview Guide and use GRID scoring, in which dimensions of intensity and frequency of a symptom are rated independently for each item. Higher scores reflect greater symptom severity, categorized as Normal (0-7), Mild Depression (8-13), Moderate Depression (14-18), Severe Depression (19-22), and Very Severe Depression (\>23).
Change from baseline depression severity at the final assessment
Change in depression diagnosis via Structured Clinical Interview for DSM-5 Disorders (SCID)
This is a clinician-administered semi-structured interview guide for making diagnoses according to the diagnostic criteria published in the American Psychiatric Association's Diagnostic and Statistical Manual for Mental Disorders (DSM-5). It provides diagnoses for depressive and bipolar disorders, schizophrenia spectrum and other psychotic disorders, substance use disorders, anxiety disorders (panic disorder, agoraphobia, social anxiety disorder, generalized anxiety disorder), obsessive-compulsive disorder, posttraumatic stress disorder, attention-deficit/hyperactivity disorder, and adjustment disorder. The SCID will be administered by a Clinical Interviewer to diagnose Major Depressive Disorder and assess for exclusion criteria in this study.
Change from baseline depression diagnosis at the final assessment
Change in depressive symptoms severity via the Quick Inventory of Depressive Symptoms (QIDS)
This is a self-administered 16-item questionnaire that assesses the severity of nine depressive symptoms in the last 7 days. Each item is rated on a 4-point scale (0-3), with total scores ranging from 0-27. Higher scores indicate more severe depression.
Change from baseline depression symptoms severity at the final assessment
Change in Transcranial Doppler ultrasound of Middle Cerebral Artery (MCA) blood flow velocity
Middle Cerebral Artery (MCA) blood flow velocity will be measured under supine, resting conditions using non-invasive techniques following 10 min of quiet rest in a dimly lit room. It will be assessed in duplicate and averaged for analyses. Measurements will be taken from the left middle cerebral artery (MCA) following standardized, recommended insonation protocols using a 2-MHz Transcranial Doppler (TCD) probe secured to the temporal window via a headset. MCA mean blood velocity will be calculated using a standard algorithm implemented on the device, averaged over a 60-sec epoch.
Change in baseline blood flow velocity at the final assessment
Change in Transcranial Doppler ultrasound of Middle Cerebral Artery (MCA) blood flow pulsatility
Middle Cerebral Artery (MCA) blood flow pulsatility will be measured under supine, resting conditions using non-invasive techniques following 10 min of quiet rest in a dimly lit room. It will be assessed in duplicate and averaged for analyses. Measurements will be taken from the left middle cerebral artery (MCA) following standardized, recommended insonation protocols using a 2-MHz Transcranial Doppler (TCD) probe secured to the temporal window via a headset. Cerebral pulsatility will be quantified using the pulsatility index, calculated as (systolic -diastolic velocity)/mean velocity using TCD, averaged over a 60-sec epoch.
Change in baseline blood flow pulsatility at the final assessment
Secondary Outcomes (11)
Columbia-Suicide Severity Rating Scale (CSSRS)
Weeks 0, 8, 16, 26
Estimated 1 Repetition Maximum (RM) Strength Test
Weeks 0, 8, 16, 26
Grip Strength
Weeks 0, 8, 16, 26
Arterial Stiffness
Weeks 0, 8, 16, 26
Carotid Structure
Weeks 0, 8, 16, 26
- +6 more secondary outcomes
Study Arms (1)
Resistance Exercise Training
EXPERIMENTALParticipants will complete a 16-week, twice/week program to increase strength.
Interventions
Participants will complete a 16-week, twice/week supervised resistance exercise training program to increase strength. Each session will last \~60 minutes and begin and end with a 5-minute aerobic warm-up/cool-down on a cycle ergometer, elliptical, treadmill, or walked laps. Training will begin with a 1-week standard familiarization process to introduce participants to the machines, teach correct lifting techniques, and ensure participant safety and comfort with each exercise machine. Participants will perform 3 sets of 8-12 repetitions on 10 Keiser resistance machines (i.e., leg press, hamstring curl, quadriceps extension, chest press, lat pulldown, shoulder press, biceps curl, triceps extension, abdominal crunch), with a 1-minute rest time between each set. Workload will begin at 50% of the estimated 1-RMs and increase by 5-10% after any session in which a participant completes 12 repetitions in all 3 sets. The workload will be tailored based on progressive increases in strength.
Eligibility Criteria
You may qualify if:
- Be diagnosed with DSM-5 (Diagnostic and Statistical Manual of Mental Disorders) MDD confirmed via Structured Clinical Interview for DSM-5
- Have current depressive symptoms of at least mild severity defined by a Hamilton Rating Scale of Depression score greater than or equal to 8
- Be ages 18-65
- Have not changed psychological treatments (including drugs, behavioral and psychological treatments) in the past 8 weeks and willing to maintain treatments throughout study enrollment
- Safe to exercise based on Physical Activity Readiness Questionnaire (PARQ) responses
You may not qualify if:
- Currently pregnant, nursing, or planning to become pregnant during the study
- Currently diagnosed with a drug or alcohol use disorder (via SCID)
- Comorbid psychiatric conditions confirmed via SCID, with the exception of Generalized Anxiety Disorder (GAD; due to high comorbidity)
- Class II or greater level of obesity (BMI greater than or equal to 35)
- High active suicidal ideation with specific plan and intent ('4' or '5' score on Suicidal Ideation from Columbia Suicide Severity Rating Scale or '3' on QIDS)
- Currently meets US resistance exercise recommendations per week (2 days per week) for the last 8 weeks
- Self-reported prior cardiovascular event or condition, stroke or pulmonary, renal, or neurological disease
- Self-reported diabetes mellitus
- Self-reported recent (within 3 months) severe concussion, in which the individual lost consciousness for any amount of time
- Self-reported smoking/vaping
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Iowa State University
Ames, Iowa, 50011, United States
Related Publications (1)
Meyer JD, Perkins SL, Gidley JM, Kuzniar JM, Phillips LA, Lansing JL, Wade NG, Herring MP, Lefferts WK. Feasibility and preliminary efficacy of a theory-informed resistance exercise training single-arm intervention for major depression. Psychol Sport Exerc. 2024 Jul;73:102642. doi: 10.1016/j.psychsport.2024.102642. Epub 2024 Apr 12.
PMID: 38615899DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor of Kinesiology
Study Record Dates
First Submitted
December 14, 2022
First Posted
January 25, 2023
Study Start
April 4, 2022
Primary Completion
November 11, 2022
Study Completion
January 10, 2023
Last Updated
March 5, 2024
Record last verified: 2024-03
Data Sharing
- IPD Sharing
- Will not share
There are no known plans for future use.